In addition to acting on neuronal cells, GLP-1R agonists also exert effects on microglia and astrocytes through cAMP/PKA signaling pathway
While head-to-head comparison is lacking, CagriSema seems more effective in promoting weight reduction than the dual agonist of GLP-1R and gastric inhibitory polypeptide (GIP) receptor, tirzepatide (table 2)
May 25, 2026$200/mo July 6, 2026$200/mo July 13, 2026$200/mo July 20, 2026$200/mo July 27, 2026$200/mo We check Ivim Healths published pricing every Monday
Tell your doctor if you are breast-feeding
Patients with questions about an order, prescription, or medication, please call (866) 506-2174 and ask to speak to a pharmacist
Key documentation to prepare: 6+ months of weight management records (dietitian visits, gym membership, food logs), lab work showing relevant biomarkers (A1C, lipid panel, blood pressure), a letter of medical necessity from your prescriber explaining why tirzepatide specifically is needed over alternatives, and any records of prior medication trials that were inadequate